Fred D. Lott
Impact in
- Pharmaceutical Science top 10%
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
Papers in
-
- Inflammatory mediators and NSAID effects 6
-
- Inhalation and Respiratory Drug Delivery 3
- Neonatal Respiratory Health Research 2
- Co-authors
- Ralph W. Niven (3 shared papers)Michael R. Littner (10 shared papers)Chen Dong (1 shared paper)Ning Sun (1 shared paper)Yeonseok Chung (1 shared paper)Hilary Chute (1 shared paper)Carole Kurahara (1 shared paper)Yongliang Zhang (1 shared paper)
- Journals
- Journal of Applied Physiology (4 papers)Pharmaceutical Research (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United States
In The Last Decade
Fred D. Lott
19 papers receiving 320 citations
Peers
Comparison fields: 5 of 74
- Pharmaceutical Science 35
- Immunology 113
- Pulmonary and Respiratory Medicine 114
- Oncology 81
- Developmental Neuroscience 10
Countries citing papers authored by Fred D. Lott
This map shows the geographic impact of Fred D. Lott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred D. Lott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred D. Lott more than expected).
Fields of papers citing papers by Fred D. Lott
This network shows the impact of papers produced by Fred D. Lott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred D. Lott. The network helps show where Fred D. Lott may publish in the future.
Co-authors
The 25 scholars most cited alongside Fred D. Lott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 134 | |
| 2 | 1994 | 43 | |
| 3 | 1993 | 34 | |
| 4 | 1989 | 18 | |
| 5 | 1994 | 17 | |
| 6 | 2009 | 17 | |
| 7 | 1996 | 14 | |
| 8 | 2006 | 13 | |
| 9 | 1986 | 13 | |
| 10 | 1985 | 9 | |
| 11 | 1984 | 8 | |
| 12 | 1982 | 5 | |
| 13 | 1998 | 4 | |
| 14 | 1987 | 3 | |
| 15 | 1994 | 3 | |
| 16 | 1987 | 3 | |
| 17 | 1990 | 2 | |
| 18 | 1988 | 1 | |
| 19 | 1994 | 1 | |
| 20 | Evaluation of a Methodology for the Reverse Engineering and Parallelization of Sequential Code | 1999 | 0 |
About Fred D. Lott
Fred D. Lott is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine, Biochemistry, Physiology and Molecular Biology, having authored 20 papers that have together received 342 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Asthma and respiratory diseases (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Cardiac Ischemia and Reperfusion (2 papers), Neonatal Respiratory Health Research (2 papers), Metabolism and Genetic Disorders (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Pharmaceutical Science (35 citations), Immunology (113 citations), Pulmonary and Respiratory Medicine (114 citations), Oncology (81 citations) and Developmental Neuroscience (10 citations). Fred D. Lott has collaborated with scholars based in United States. Frequent co-authors include Ralph W. Niven, Michael R. Littner, Chen Dong, Ning Sun, Yeonseok Chung, Hilary Chute, Carole Kurahara, Yongliang Zhang, Andrew A. Welcher and Christopher F. Toombs. Their work appears in journals such as Journal of Applied Physiology, Pharmaceutical Research, Journal of Pharmacology and Experimental Therapeutics, American Journal of Respiratory and Critical Care Medicine and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.